Investing Profile

Andrew Adams

InvestorVC
Co-Founder & Managing Partner at Oak HC/FT
Photo of Andrew Adams, Managing Partner at Oak HC/FT

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Oak HC/FT Managing Partner
$5.0M - $50.0M
$25.0M
26
$800M
CompanyStageDateRound SizeTotal Raised
Trovo Health
SeedApr 2024$15M
$15M
Co-investors: Vignesh Chandramouli (Oak HC/FT)
August Bioservices
Series BDec 2022$65M
Series AMay 2021$24M
Series UnknownJul 2020
$89M
Co-investors: Darren Carroll (Polaris Partners), Brian Chee (Polaris Partners)
DispatchHealth
Series ENov 2022$330M
Series DMar 2021$200M
Series CJun 2020$140M
$730M
Co-investors: Scott Shleifer (Tiger Global Management), Ryan Drant (Questa Capital), Dusty Lieb (Echo Health Ventures), Larry C. Renfro (Optum Ventures)
Rialtic
Series AMar 2022$28M
$28M
Co-investors: Carl Byers (F-Prime Capital Partners)
Reveleer
Series UnknownDec 2021$65M
$84M
Co-investors: Yves Sisteron (Upfront Ventures)
Infusion for Health
Series UnknownNov 2021$50M
$50M
VEDA Data Solutions
Series BJul 2021$45M
$46M
Co-investors: John Carleton
DTx Pharma
Series BMar 2021$100M
Series AJan 2020$11M
$140M
Co-investors: Martin Alexander Gershon (Endeavor Venture Funds), Cristina Escoda (Tachyon Ventures), Dan Becker (Access Biotechnology)